Shared by
beno
Fundamentals
N/a
Catalysts / News / Painting the picture
-Corona virus sympathy
-Health officials say virus vaccine development has 'no glitches'
-Feb 11 2020: $500m IPO @ $19 per share
-mRNA-1273 coronavirus vaccine sent for testing
-March 16 2020: First human trial of COVID-19 vaccine
Technical Analysis
-Intraday pattern: Mountain
-Levels: 27.50, 29, 30, 31, 32.50
Original Plan / Strategy
First test long of 28.50 with half dollar confluence
Review
Started scaling into this trade but noticed continued selling right away and added one lot at 28.40. Noticed more selling and pushing price below 28.40 and simply cut the trade. By the time I noticed buying come back in it was too late to chase. I didn't give this trade the benefit of the doubt, it only went 15 cents against my level. Could have easily gotten bigger and made this OGT!
Lessons Learned: Give trades the benefit of the doubt it they're still holding at the top of your technical level / consolidation zone!
Execution detail:
| Date/time | Symbol | Side | Price | Position |
|---|---|---|---|---|
| 2020-03-17 13:49:47 | MRNA | buy | $28.560 | long |
| 2020-03-17 13:49:58 | MRNA | buy | $28.400 | long |
| 2020-03-17 13:50:00 | MRNA | sell | $28.369 | 0 |
Leave a comment about this trade!
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!